Nancy J. Hutson - 29 Oct 2021 Form 4 Insider Report for Clearside Biomedical, Inc. (CLSD)

Role: Director
Signature: /s/ Mark Ballantyne, Attorney-in-Fact
Issuer symbol: CLSD
Transactions as of: 29 Oct 2021
Net transactions value: +$81,350
Form type: 4
Filing time: 02 Nov 2021, 16:40:17 UTC
Previous filing: 19 Oct 2021
Next filing: 08 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLSD	Common Stock	Options Exercise	$50,000	+25,000	+192%	$2.00	38,000	29 Oct 2021	Direct
transaction	CLSD	Common Stock	Options Exercise	$31,350	+15,000	+39%	$2.09	53,000	29 Oct 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CLSD	Stock Option (right to buy)	Options Exercise	$0	-25,000	-100%	$0.000000^*	0	29 Oct 2021	Common Stock	25,000	$2.00	Direct	F1
transaction	CLSD	Stock Option (right to buy)	Options Exercise	$0	-15,000	-50%	$0.000000	15,000	29 Oct 2021	Common Stock	15,000	$2.09	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares underlying this option were fully vested as of June 18, 2021.
F2	This option will vest and become exercisable in 36 equal monthly installments beginning on May 21, 2020, subject to the Reporting Person's continuous service as of such vesting dates.